Bangkok (14 May 2024) – MEDEZE Group Public Company Limited is a leading institute that offers comprehensive services encompassing the harvesting, isolation, culturing, and research of stem cells, with world-class quality standard awards. MEDEZE Group has announced a crucial collaboration with “Bangkok Chain Hospital Company Limited”, Kasemrad Hospital Group, Kasemrad Hospital Group International, Karunvej Hospital Group, and World Medical Hospital Group. These are leading hospitals in Thailand, with 14 branches domestically and one branch abroad, sharing a vision of becoming premier healthcare service providers in both Thailand and Southeast Asia.
The inauguration of the Cell Harvesting Center, boasting standard, safety, along with advanced modern and comprehensive medical technologies, elevates Thailand to being the medical hub of Southeast Asia with world-class trending technological innovations to enable individuals of all ages, including newborns, to have their stem cells stored. The global value of this market is immeasurable as everyone can have their stem cells and immune cells cryopreserved.
The Cell Harvesting Center targets clients whose product or service consumption behaviors and lifestyles differ from others. These clients typically prioritize investing in their health and seek alternatives that employ progressive innovations to enhance their longevity, quality of life, and vitality.
Veerapol Khemarangsan, M.D., Chief Executive Officer of MEDEZE Group Public Company Limited revealed that “In the modern world, people are confronted with an acute problem stemming from the well-being crisis exacerbated by environmental changes and pollution—such as PM 2.5—as well as the constantly escalating number of elderly individuals, which has led to a fully-fledged aging society, as well as the Covid-19 pandemic and various mutated diseases. MEDEZE Group realizes the significance of such changes in the world and has been in operation for 14 years to promote health sustainability worldwide, dedicated to offering new alternatives that enable people’s longevity and their better tomorrow through the BIOlongevity which includes the most comprehensive services. At present, we hold the number one position in ASEAN for the total number of harvested stem cells and are trusted by clients worldwide. That’s because every process, from cell harvesting to culturing, was devised based on research certified by world-class institutions. We pay meticulous attention to every detail, resulting in several international quality guarantee awards. For example, four consecutive years of Frost & Sullivan Best Practices Awards as Thailand’s Stem Cell Banking Company of the Year, World Branding Awards by World Branding Forum, the regional award South East Asia Stem Cell Banking Technology Innovation, Leadership Award, and the latest 2021-2024Southeast Asia Stem Cell Banking Company of the Year Award* I Frost & Sullivan Awards …From the domestic success to becoming the top player in the region.
We are also accredited by another world-class institution, that is, the Association for the Advancement of Blood & Biotherapies (AABB), which is the strictest agency certifying and stipulating standards and guidelines for the operation of stem cell banks. This quality standard covers all processes of activities involving hematopoietic stem cells (HPCs) derived from cord blood, from long-term storage to global distribution, enabling patient treatment all over the world.”
Veerapol, M.D., made an interesting remark on stem cell banking technology, saying, “In the past, there was a belief that mesenchymal stem cells (MSCs) should exclusively be collected from newborns’ cord tissue. It is only MEDEZE Group that has diligently endeavored to develop this stem cell isolation and culture innovation from adipose tissue to provide everyone, including folks like myself who missed the opportunity to have their stem cells harvested at birth, with another chance to obtain the best stem cell harvesting.”
Having MSCs stored for yourselves in the future constitutes a safe and ethically sound approach to taking care of human health. MEDEZE Group controls banking standards by freezing them at -196 degrees Celsius in liquid nitrogen vapor to maintain their efficacy over the long term. Offering a 60-year banking policy, MEDEZE Group provides the longest care period in the stem cell bank industry. Additionally, MEDEZE GROUP PTE. LTD. (Singapore Branch) has developed the innovation of artificial organ generation from stem cells, with one organ having been successfully created, that is, “cornea”.
Veerapol, M.D., further elaborated, “On a global scale, the competition in developing the use of stem cells and immune cells for human health, life quality, longevity, and happiness results in dramatic advancements in innovation. However, if we aspire to get into this way, we should first have our stem cells stored to pause the aging process at its current stage. This will serve as the starting point for everyone to further utilize these cells. So, initiating the process by collecting cells from quality cord blood/cord tissue/adipose tissue through medically correct procedures is crucial. That’s why top-quality infirmaries of the BCH Group’s hospitals serve as excellent Cell Harvesting Center in all aspects.”
Prof. Dr. Chalerm Harnphanich, M.D., Chief Executive Officer of Bangkok Chain Hospital Public Company Limited, said that “Bangkok Chain Hospital Public Company Limited, Kasemrad Hospital Group, Kasemrad Hospital Group International, Karunvej Hospital Group, and World Medical Hospital Group are leading hospitals in Thailand, with 14 branches domestically and one branch abroad, sharing a vision of becoming premier healthcare service providers in both Thailand and Southeast Asia. The company is dedicated to offering modern and comprehensive medical services to cultivate confidence among service users. One of our missions is to collaborate with business partners to enhance effectiveness in various aspects and achieve success together. We aim to build confidence in our health services to secure the top position in patients’ preferences. Today, we’ve collaborated with MEDEZE Group in establishing the Cell Harvesting Center, which affirms our potential to provide our patients with all-around care.”
Prof. Dr. Chalerm Harnphanich, M.D., said further, “The inauguration of the Cell Harvesting Center of BCH Group’s hospitals aims to provide services for service users across Bangkok and beyond, including international health-conscious individuals, who seek to have their quality stem cells and immune cells harvested, and to ensure the safety of every procedure. As a result, this initiative lays the foundation for the health of people of all ages and genders through hospitals with high medical standards and impressive services from BCH Group’s hospitals.”
About MEDEZE Group Public Company Limited
MEDEZE Group Public Company Limited is a global leading institute that offers comprehensive services encompassing the harvesting, isolation, culturing, and research of stem cells from cord blood, cord tissue, and adipose tissue. We are the world’s largest and Thailand’s most experienced mesenchymal stem cell bank. Moreover, we are also the first company worldwide to offer services such as the NK Cell activity test and NK Cell expansion by the Osaki Method, which is patented in Japan. We employ skills, expertise, and innovations to provide the most advanced medical services, alongside the research and development team, to further existing regenerative treatments, including patents for cell culture expansion technologies, with the aim of facilitating the limitless use of stem cells to achieve better medical outcomes.
We received several international quality guarantee awards. For example, four consecutive years of Frost & Sullivan Best Practices Awards as Thailand’s Stem Cell Banking Company of the Year, World Branding Awards by World Branding Forum, the regional award Southeast Asia Stem Cell Banking Technology Innovation Leadership Award, and the latest 2021-2024 Southeast Asia Stem Cell Banking Company of the Year Award* I Frost & Sullivan Awards. Further, our standards got a world-class guarantee by the Association for the Advancement of Blood & Biotherapies (AABB) covering all processes of activities involving hematopoietic stem cells (HPCs) derived from cord blood, from long-term storage to global distribution, enabling patient treatment all over the world. Currently, MEDZE Group has branches in various countries across the region, such as Vietnam, Myanmar, Singapore, Cambodia, and Indonesia—with the principal office located in Thailand.
About Bangkok Chain Hospital Public Company Limited
Bangkok Chain Hospital Public Company Limited (“BCH”) commenced its hospital operations in 1984 and has consistently expanded its business since then. Over the years, BCH has emerged as one of the leaders in healthcare services and is currently the largest service provider for insured persons in Thailand’s Social Security Project.
The company operates its business in the form of a hospital group with 15 affiliated hospitals and two polyclinics located in Bangkok and beyond, including Lao PDR. These facilities provide medical services ranging from primary to tertiary levels under four hospital groups: 1. World Medical Hospital Group; 2. Kasemrad Hospital Group International; 3. Kasemrad Hospital Group; and 4. Karunvej Hospital Group. The objective is to ensure that the services cover all categories of patients, including general patients, foreigners, and patients covered under the Social Security Project.
- The company received an “AA” ranking in sustainable stocks (SET ESG Ratings) in 2023, as assessed by the Stock Exchange of Thailand.
- The company rating was affirmed at “A” with a “stable” outlook by TRIS Rating.
- The assessment result by the Corporate Governance Report for Thai Listed Companies of the year 2023 is excellent, indicated by a five-star symbol.
- Ranking in the ESC100 directory for the 6th consecutive year demonstrates the distinctive business operation in environment, society, and good governance by Thaipat Institute.
- The company received the second renewal from the Thai Private Sector Collective Action Against Corruption.
- The company received a Certificate of Appreciation for Sustainability Disclosure Recognition regarding the disclosure of sustainability information in the year 2023, awarded by Thaipat Institute.
